Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


29.01.2018

6 Aliment Pharmacol Ther
4 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
12 Inflamm Bowel Dis
1 J Clin Gastroenterol
3 J Crohns Colitis
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. MANOSA M, Calafat M, de Francisco R, Garcia C, et al
    Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
    Aliment Pharmacol Ther. 2018 Jan 25. doi: 10.1111/apt.14494.
    PubMed     Text format     Abstract available

  2. WALJEE AK, Liu B, Sauder K, Zhu J, et al
    Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis.
    Aliment Pharmacol Ther. 2018 Jan 22. doi: 10.1111/apt.14510.
    PubMed     Text format     Abstract available

  3. SWEENEY L, Moss-Morris R, Czuber-Dochan W, Meade L, et al
    Systematic review: psychosocial factors associated with pain in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018 Jan 22. doi: 10.1111/apt.14493.
    PubMed     Text format     Abstract available

  4. NAKASE H, Motoya S, Matsumoto T, Watanabe K, et al
    Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.
    Aliment Pharmacol Ther. 2017;46:873-882.
    PubMed     Text format     Abstract available

  5. DING NS, Malietzis G, Lung PFC, Penez L, et al
    The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm.
    Aliment Pharmacol Ther. 2017;46:883-891.
    PubMed     Text format     Abstract available

  6. CARDING SR, Davis N, Hoyles L
    Review article: the human intestinal virome in health and disease.
    Aliment Pharmacol Ther. 2017;46:800-815.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. FEUERSTEIN JD, Curran T, Alosilla M, Cataldo T, et al
    Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4922.
    PubMed     Text format     Abstract available

  8. LUKACH AJ, Saul MI, Ferris LK, Swoger JM, et al
    Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-018-4919.
    PubMed     Text format     Abstract available

  9. BODEN EK, Shows DM, Chiorean MV, Lord JD, et al
    Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4924.
    PubMed     Text format     Abstract available

  10. FERNANDEZ-BLANCO JI, Fernandez-Diaz G, Cara C, Vera MI, et al
    Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4935.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  11. HERZOG D, Fournier N, Buehr P, Rueger V, et al
    Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
    Eur J Gastroenterol Hepatol. 2018 Jan 22. doi: 10.1097/MEG.0000000000001072.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  12. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  13. GOYAL A, Yeh A, Bush BR, Firek BA, et al
    Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:410-421.
    PubMed     Text format     Abstract available

  14. HABERMAN Y, BenShoshan M, Di Segni A, Dexheimer PJ, et al
    Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Inflamm Bowel Dis. 2018;24:346-360.
    PubMed     Text format     Abstract available

  15. MACALUSO FS, Sapienza C, Ventimiglia M, Renna S, et al
    The Addition of an Immunosuppressant After Loss of Response to Anti-TNFalpha Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
    Inflamm Bowel Dis. 2018;24:394-401.
    PubMed     Text format     Abstract available

  16. ROLSTON VS, Boroujerdi L, Long MD, McGovern DPB, et al
    The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.
    Inflamm Bowel Dis. 2018;24:387-393.
    PubMed     Text format     Abstract available

  17. PRATT PK JR, David N, Weber HC, Little FF, et al
    Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Inflamm Bowel Dis. 2018;24:380-386.
    PubMed     Text format     Abstract available

  18. PIESTER T, Frymoyer A, Christofferson M, Yu H, et al
    A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:227-234.
    PubMed     Text format     Abstract available

  19. LARSEN L, Drewes AM, Broberg MCH, Fallingborg J, et al
    Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Inflamm Bowel Dis. 2018;24:433-439.
    PubMed     Text format     Abstract available

  20. RAO BB, Lashner B, Kowdley KV
    Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Trasnplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018;24:269-276.
    PubMed     Text format     Abstract available

  21. O'TOOLE A, de Silva PS, Marc LG, Ulysse CA, et al
    Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.
    Inflamm Bowel Dis. 2018;24:310-316.
    PubMed     Text format     Abstract available

  22. HUGUET M, Pereira B, Goutte M, Goutorbe F, et al
    Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:261-268.
    PubMed     Text format     Abstract available

  23. SCOTT FI, Shah Y, Lasch K, Luo M, et al
    Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model.
    Inflamm Bowel Dis. 2018;24:286-295.
    PubMed     Text format     Abstract available

  24. YARLAS A, D'Haens G, Willian MK, Teynor M, et al
    Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Inflamm Bowel Dis. 2018;24:450-463.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  25. DAI C, Jiang M, Sun MJ
    The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2018 Jan 23. doi: 10.1097/MCG.0000000000000996.
    PubMed     Text format    


    J Crohns Colitis

  26. LASERNA-MENDIETA EJ, Clooney AG, Carretero-Gomez JF, Moran C, et al
    Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.
    J Crohns Colitis. 2018;12:204-216.
    PubMed     Text format     Abstract available

  27. ANDERSEN V, Chan S, Luben R, Khaw KT, et al
    Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD).
    J Crohns Colitis. 2018;12:129-136.
    PubMed     Text format     Abstract available

  28. ZHU Z, Mei Z, Guo Y, Wang G, et al
    Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis.
    J Crohns Colitis. 2018 Jan 23. pii: 4822002. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  29. MENDALL M, Harpsoe MC, Kumar D, Andersson M, et al
    Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort.
    PLoS One. 2018;13:e0190600.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: